RenoRisk : Validating a Novel Biomarker Panel for Early CKD Risk Detection and Treatment Monitoring

• Unité de recherche: INNOSUISSE
• Numéro de projet: 130.014 IP-LS
• Titre du projet anglais: RenoRisk : Validating a Novel Biomarker Panel for Early CKD Risk Detection and Treatment Monitoring

Mots-clé (Anglais)

Life sciences, Personalised medicine

Résumé des résultats (Abstract) (Anglais)

Early detection of CKD is key to improving outcomes and guiding nephroprotective decisions. This project validates RenoRisk, a novel biomarker panel discovered in Alport Syndrome and cross-species, identified as a predictor of CKD progression in at-risk adults with hypertension and type 2 diabetes.